
    
      Patients will receive 5-ppm study gas (nitric oxide for inhalation or placebo) until Day 28
      or extubation, whichever comes first. The following will be performed / recorded at specified
      times during the study: arterial blood gases, ventilator settings, methemoglobin, PRISM III
      score, and patient positioning. Selected centers will also be performing plasma cytokine
      assays, broncho-alveolar lavage fluid assays and a 6 month follow-up assessment.
    
  